Chicago - according to the results of randomized trials, ginseng helps cancer patients recover from fatigue. Dr. Barton Debra, the nurse Min
Chicago - according to the results of randomized trials, ginseng helps cancer patients recover from fatigue. Dr. Barton Debra, the nurse Minnesota Mayo Clinic Cancer Center in Rochester, and her colleagues found that taking ginseng powder after 8 weeks, patients with cancer fatigue scale scores than the control group (decreased 10% P=0.003) decreased by 20%. According to the American Society of Clinical Oncology meeting report, at least in the short term, ginseng exhibits a placebo like safety profile. "It's an exciting finding that we have no choice or only a limited choice in alleviating cancer induced fatigue," said Sriram, MD, PhD, of the Anderson cancer center at Yennu. Some cancer patients will feel tired. Fatigue is common at the beginning of cancer treatment and continues to some extent after the end of treatment. Erythropoietin drugs may be effective in relieving the fatigue, but once stopped, it can lead to a serious risk of death and cardiovascular disease, as well as the risk of venous thromboembolism. About 80% of cancer patients are treated with some form of adjuvant therapy, Yennu said in an interview today. He pointed out that ginseng is a popular choice, and its results in the relief of fatigue is also gratifying. Ginseng is a traditional Chinese herbal medicine, as a natural energy enhancer. It is thought to act as an anti-inflammatory or by regulating the stress hormone cortisol. He suggested that ginseng has been shown to have very low side effects, but also to carry out 4 to 8 weeks of ginseng test to confirm whether the patient is reasonable. "It is not considered to be a standardized treatment," Yennu explained. "We need further studies to confirm the safety of the treatment." III's phase Barton trial included 40 sites, 364 cases of cancer patients with at least moderate fatigue records (fatigue scale, 10 points for a score of 4 or more), to exclude such as anemia, pain, insomnia and other factors caused by fatigue. Take a double-blind trial, subjects were given in the morning 2 capsules containing 2000mg ginseng powder or placebo capsules. After 4 weeks, the ginseng group showed a multidimensional fatigue symptom scale score change. With 100 points, the medication group increased by, the control group increased by 8.2 points (P=0.07). After 8 weeks, the advantage of the drug group was statistically significant. The fatigue score of the treatment group was 20 points higher than that of the baseline, while the control group had a score of (P=0.003). The efficacy of the treatment group was reduced physical fatigue. 10 points of physical health symptom scale, the drug group increased by 3 points, while the control group decreased by (P=0.004). There was no significant difference in the psychological, emotional and spiritual aspects between the medication group and the control group. Ginseng seems to be the most effective drug for cancer treatment. There was a significant difference in the improvement of fatigue compared with placebo (P=0.01), but the effect was not significant for cancer treatment (P=0.07). Side effects after 8 weeks of continuous administration of common nausea (treatment group 5%, control group 4% (4%) and diarrhea medication group, control group 3%). It is reported that 1% to 2% of patients taking ginseng after vomiting, occasionally other sleep disorders, recorded in the appendix of anxiety, tension etc.. The incidence of adverse events of 3 or grade of patients in the treatment group was not higher than that of the control group, and the incidence of adverse events was 8% in the control group, and there was no significant difference between the two groups in the control group (6%). Fatal adverse events were dizziness, white blood cells, and neutrophils. The Barton team concluded: "American ginseng has no apparent toxicity". Further studies are needed to determine the long-term safety and efficacy of Yennu because of cancer induced fatigue for ten years.